Autoinflammatory diseases are a group of rare, primarily monogenic disorders characterized by recurrent episodes of systemic inflammation in the absence of high-titer autoantibodies or antigen-specific T cells.
These conditions result from dysregulation of the innate immune system, often due to mutations in genes involved in the inflammatory response. Common symptoms include recurrent fever, rash, joint pain, and abdominal discomfort. Conditions such as Familial Mediterranean Fever, Cryopyrin-Associated Periodic Syndromes, and TNF Receptor-Associated Periodic Syndrome fall under this category. Diagnosis is typically based on clinical presentation, genetic testing, and exclusion of other inflammatory conditions. Treatment varies based on the underlying condition and may include nonsteroidal anti-inflammatory drugs, colchicine, corticosteroids, and biologics targeting specific inflammatory pathways. In rare cases, hematopoietic stem cell transplantation may be necessary to cure the disease. Given their complexity and rarity, these diseases often require specialized care and ongoing monitoring.
Il Simposio SwissRITA si terrà il 10 aprile 2026 presso l’Ospedale universitario pediatrico di Zurigo.
Le Symposium SwissRITA aura lieu le 10 avril 2026 à l’Hôpital universitaire pédiatrique de Zurich.
Am 10. April 2026 findet das SwissRITA Symposium am Universitäts-Kinderspital Zürich statt.
The SwissRITA Symposium will take place on 10 April 2026 at the University Children’s Hospital Zurich.